Tech Company Financing Transactions

Kite Pharma Funding Round

Kite Pharma closed a $20 million Series A funding round on 5/15/2013. Backers included Alta Partners, Commercial Street Capital and private investors.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

2400 Bdwy.
Santa Monica, CA 90404
USA

Phone

(310) 824-9999

Website

www.kitepharma.com

Email Address

[email protected]

Overview

Kite Pharma, Inc. (NASDAQ: KITE) is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Arie Belldegrun

        

Chief Financial Officer

Cynthia Buttita

        

Chief Scientific Officer

Margo Roberts

        

VP - Bus. Development

Helen Kim

        

VP - R & D

David Chang

        

Browse more venture capital transactions:

Prev: 5/15/2013: Tokai Pharmaceuticals venture capital transaction
Next: 5/15/2013: StepLeader venture capital transaction

Share this article

About Database of VC Transactions

Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary